Clinical Trial

Clinical Protocol CERN Feasibility Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if the intravaginal Cern device works to treat bacterial vaginosis and fungal vaginitis in premenopausal women. It will also learn about the safety of the device. The main questions it aims to answer are: Does the device accomplish symptom resolution and negative diagnostic tests post-treatment? What medical problems do participants have when using the intravaginal device? Participants will use the investigational intravaginal device for 5 consecutive days, participate in teleconferences and weekly follow-ups, attend in-clinic visits, and maintain a study diary.
Trial Details
NCT Number NCT06933420
Lead Sponsor Cern Corporation
Conditions Bacterial Vaginosis, Fungal Vaginal Infections
Enrollment 9 participants
Start Date 2024-11-06
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-04-18